Characterization of MK-4166, a Clinical Agonistic Antibody That Targets Human GITR and Inhibits the Generation and Suppressive Effects of T Regulatory Cells
Year: 2017
Type: article
Source: Cancer Research
Authors: Selvakumar Sukumar, Douglas C. Wilson, Ying Yu, Jerelyn Wong, Saraswathi Naravula, Grigori Ermakov, Romina Riener, Bhagyashree Bhagwat, Antoaneta S. Necheva, Jeff Grein, Tatyana Churakova, Ruban Mangadu, Peter Georgiev, Denise Manfra, Elaine M. Pinheiro, Venkataraman Sriram, Wendy J. Bailey, Danuta Herzyk, Terrill K. McClanahan, Aarron Willingham, Amy M. Beebe, Svetlana Sadekova
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Topic: T-cell and B-cell Immunology
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2626962960
